Clinical Trials Directory

Trials / Unknown

UnknownNCT04322331

Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer

The Different Transcriptional Characterization Of The Tumor Immune Microenvironment of Luminal A Breast Cancer With Different Lymph Node Metastasas Status

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Luminal type A breast cancer is a type with good clinical prognosis, and the proportion of lymph node metastasis is low, but a small number of patients have more lymph node metastasis when the primary tumor is very small, and the survival is poor, suggesting that this part of Luminal A breast cancer has the different expression of some genes from that of general Luminal A breast cancer, which affects tumor invasion and participates in the occurrence of tumor metastasis. But the mechanism is not clear, especially in the current tumor microenvironment and immune related mechanisms.We want to investigated the relationship of the transcriptional tumor immune microenvironment with early lymph node metastasis among Luminal A type breast cancer.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2020-05-01
Primary completion
2021-05-01
Completion
2021-12-31
First posted
2020-03-26
Last updated
2020-03-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04322331. Inclusion in this directory is not an endorsement.